Dr. Reddy's Recalls Zoledronic Acid Injection Due to Unknown Impurities
Dr. Reddy's Laboratories is recalling Zoledronic Acid Injection vials because they failed impurity specifications with out-of-specification unknown impurities.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences.
Plain-English summary
Dr. Reddy's Laboratories, Inc. is recalling 59,468 vials of Zoledronic Acid Injection, 5mg/100 mL (0.05 mg/mL) 100ml vial. The product is a prescription-only medication manufactured by Gland Pharma Limited in India for Dr. Reddy's Laboratories Limited. The recall is due to the product failing impurities and degradation specifications, specifically showing out-of-specification (OOS) results for unknown impurities.
The affected product was distributed to retailers, distributors, physician offices, and medical facilities throughout the United States. The recall covers specific batch numbers with expiration dates ranging from September 2018 to March 2020, including batches BS633, BS701 through BS715, BS726 through BS730, and BS801.
The FDA has classified this recall as Class III, which indicates that use of or exposure to the violative product is not likely to cause adverse health consequences. Healthcare providers and patients should stop using the affected vials and contact their pharmacy or Dr. Reddy's Laboratories for further instructions.
The recalled product
- Product
- ZOLEDRONIC ACID (ZOLEDRONIC ACID)
- Brand
- ZOLEDRONIC ACID
- Manufacturer
- Dr. Reddy's Laboratories, Inc.
- Category
- Drug — Injection
- Hazard
- Affected units
- 59,468
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Batch Numbers: BS633
- EXP 9/2018
- BS701
- BS702
- BS703
- EXP 12/2018
- BS708
- BS709
- BS711
- BS712
- BS713
- BS714
- BS715
- EXP 3/2019
- BS726
- BS727
- EXP 6/2019
- BS728
- BS729
- BS730
UPCs (1)
- 0355111688525
Distribution
Distribution scope not specified by the agency.
Part of a larger recall action
This product is one of 2 recalled by Dr. Reddy's Laboratories, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 2 products in this recall →Related recalls
Same brand · ZOLEDRONIC ACID
- HighZoledronic Acid Injection Recalled for Sterility Defect
FDA (Drugs) · 2024-06-05
- LowDr. Reddy's Recalls Zoledronic Acid Injection Due to Unknown Impurities
FDA (Drugs) · 2018-10-03
- SevereDr. Reddy's Recalls Zoledronic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2016-04-06
- SevereSagent Recalls Zoledronic Acid Injection Due to Sterility Concerns
FDA (Drugs) · 2014-10-08
Same manufacturer · Dr. Reddy's Laboratories, Inc.
See all →- ModerateVarenicline tablets recalled after an assay value fell below specification
FDA (Drugs) · 2025-12-17
- Moderate
- HighOmeprazole capsule bottle contained a foreign divalproex sodium tablet
FDA (Drugs) · 2025-07-23
- SevereLevetiracetam Injection Label Mismatch Nationwide Recall
FDA (Drugs) · 2025-04-23
- ModerateFDA Recalls JAVYGTOR Tablets Due to Failed Impurities and Degradation Specifications
FDA (Drugs) · 2024-12-18
Same hazard · unknown impurities
See all →- High
- HighGlycopyrrolate 1 mg Tablets Recalled for Failed Impurity Specifications
FDA (Drugs) · 2023-01-04
- ModerateDexamethasone Elixir Recalled for Impurities Above Permissible Levels
FDA (Drugs) · 2022-03-09
- SevereUnited Pharmacy Recalls Compounded Glutamine Injection Vials Due to CGMP Deviations
FDA (Drugs) · 2017-10-18